<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Scottline Healthcare Solutions, Inc

    Scottline Healthcare Solutions, Inc

    Scottline helps healthcare organizations establish a secure, agile digital infrast...

    Scottline helps healthcare organizations establ...

    Filing Type:    RARD
    Bio-Path Holdings, Inc.

    Bio-Path Holdings, Inc.

    Bio-Path is a biotechnology company developing targeted therapies for acute myeloi...

    Bio-Path is a biotechnology company developing ...

    Filing Type:    PU
    Asprodental Inc.

    Asprodental Inc.

    Asprodental is an enterprise SaaS for dentists. All office operations, from health...

    Asprodental is an enterprise SaaS for dentists....

    Amount Raised:    $27,010.00
    Fundraising Status:    EC
    Filing Type:    CF
    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc. is a clinical–stage biopharmaceutical company fo...

    Sienna Biopharmaceuticals, Inc. is a clinicalâ€...

    Filing Type:    PU
    Flexion Therapeutics, Inc.

    Flexion Therapeutics, Inc.

    Flexion Therapeutics is a biopharmaceutical company focused on the development and...

    Flexion Therapeutics is a biopharmaceutical com...

    Filing Type:    PU
    MYOS RENS Technology Inc.

    MYOS RENS Technology Inc.

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a company based in Cedar Knolls, NJ was...

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a co...

    Filing Type:    PU
    Geron Corporation

    Geron Corporation

    Geron is a late-stage clinical biopharmaceutical company focused on the developmen...

    Geron is a late-stage clinical biopharmaceutica...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapie...

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.